Mirtazapin-Mepha 45 mg, Filmtabletten - 100 Tablette(n) Swissmedic Key 61342005 Registration Holder Mepha Pharma AG Name Mirtazapin-Mepha 45 mg, Filmtabletten Date of registration 12.04.2011 Original/Generic Generic Introduction of Sequence 12.04.2011 ATC-Classification Mirtazapine (N06AX11) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.06. Show package size 100 Tablette(n) Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 72.60 Limitation No Deductible 10 % Consumer price 95.35 Feedback FB Daily cost GTIN 7680613420056 Medication Code Synthetika Pharmacode 4911336 Disponibility
Composition Filmtablette: mirtazapinum 45 mg, lactosum monohydricum 190.35 mg, cellulosi pulvis, carboxymethylamylum natricum A corresp. natrium 0.57 mg, amylum pregelificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 6000, E 171 pro compresso obducto. Packungsbestandteile Galenic Form Filmtablette Active Agent Dose additional_information Mirtazapine 45 mg Filmtablette
BAG: Active Agent Dose Mirtazapine 45 mg
Inactive agents Dose additional_information Amylum Pregelificatum Carboxymethylamylum Natricum A Cellulosi Pulvis E 171 color. Hypromellosum Überzug Lactose Monohydrate 190.35 mg Macrogol 6000 Magnesii Stearas Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
